Dimensional Fund Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,015
| Closed | -$37.8K | – | 3514 |
|
|
2023
Q2 | $37.8K | Sell |
12,015
-18,211
| -60% | -$57.4K | ﹤0.01% | 3421 |
|
|
2023
Q1 | $80.7K | Hold |
30,226
| – | – | ﹤0.01% | 3332 |
|
|
2022
Q4 | $109 | Buy |
30,226
+702
| +2% | +$3 | ﹤0.01% | 3314 |
|
|
2022
Q3 | $190K | Buy |
+29,524
| New | +$190K | ﹤0.01% | 3249 |
|
|
2022
Q2 | – | Sell |
-22,107
| Closed | -$263K | – | 3540 |
|
|
2022
Q1 | $263K | Sell |
22,107
-9,413
| -30% | -$112K | ﹤0.01% | 3271 |
|
|
2021
Q4 | $1.03M | Buy |
31,520
+10,990
| +54% | +$358K | ﹤0.01% | 3026 |
|
|
2021
Q3 | $918K | Sell |
20,530
-10,335
| -33% | -$462K | ﹤0.01% | 3062 |
|
|
2021
Q2 | $1.68M | Sell |
30,865
-4,252
| -12% | -$232K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $2.63M | Sell |
35,117
-15,391
| -30% | -$1.15M | ﹤0.01% | 2781 |
|
|
2020
Q4 | $5.48M | Sell |
50,508
-5,772
| -10% | -$626K | ﹤0.01% | 2496 |
|
|
2020
Q3 | $4.98M | Sell |
56,280
-97
| -0.2% | -$8.58K | ﹤0.01% | 2446 |
|
|
2020
Q2 | $6.01M | Hold |
56,377
| – | – | ﹤0.01% | 2415 |
|
|
2020
Q1 | $3.34M | Buy |
56,377
+6,224
| +12% | +$369K | ﹤0.01% | 2545 |
|
|
2019
Q4 | $3.47M | Buy |
50,153
+2,691
| +6% | +$186K | ﹤0.01% | 2719 |
|
|
2019
Q3 | $4.93M | Hold |
47,462
| – | – | ﹤0.01% | 2602 |
|
|
2019
Q2 | $4.39M | Buy |
47,462
+11,118
| +31% | +$1.03M | ﹤0.01% | 2676 |
|
|
2019
Q1 | $3.32M | Buy |
36,344
+11,936
| +49% | +$1.09M | ﹤0.01% | 2772 |
|
|
2018
Q4 | $1.36M | Buy |
24,408
+9,373
| +62% | +$522K | ﹤0.01% | 2954 |
|
|
2018
Q3 | $1.79M | Buy |
+15,035
| New | +$1.79M | ﹤0.01% | 2948 |
|